NCT01495702 · Interventional trial
Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Overall registry status Completed
Phase 3
Conditions Acquired Immunodeficiency Syndrome, HIV Infections
Delaware Valley sites
- Philadelphia FIGHT · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory